← Open Payments lookup

CHRISTINA DARLING: Open Payments

NPI 1083181432 · HAVRE DE GRACE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$507 in 15 payments from 9 companies in 2025. Trend: 2023 $551 · 2024 $450 · 2025 $507

Food & beverage: $507
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.1$111
AstraZeneca Pharmaceuticals LP1$96
ABBVIE INC.5$86
Novo Nordisk Inc1$75
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$55
Vanda Pharmaceuticals Inc.1$28
Merck Sharp & Dohme LLC1$21
Novartis Pharmaceuticals Corporation1$18
Axsome Therapeutics, Inc.1$17

Products named: REXULTI, BREZTRI, Ozempic, CAPLYTA, UBRELVY, VRAYLAR, HETLIOZ, GARDASIL 9.

Industry payments across MD — which companies pay providers there.